Asthenia NOS Debility:NOS | chronic | nervous | General physical deterioration Lethargy Tiredness

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Q. whereas the Unfair Commercial Practices Directive (2005/29/EC) prohibits, in particular, any practice that ‘materially distorts or is likely to materially distort the economic behaviour with regard to the product of the average consumer whom it reaches or to whom it is addressed’, provides that commercial practices which are in all circumstances considered unfair include ‘claiming that a trader (including his commercial practices) or a product has been approved, endorsed or authorised by a public or private body when he/it has not or making such a claim without complying with the terms of the approval, endorsement or authorisation’, and requires the ...[+++]Member States to adopt effective, proportionate and dissuasive penalties; whereas Directive 2005/29/EC states that ‘a commercial practice shall be regarded as misleading if it contains false information and is therefore untruthful or in any way, including overall presentation, deceives or is likely to deceive the average consumer, even if the information is factually correct’;

O. whereas the Unfair Commercial Practices Directive (2005/29/EC) prohibits, in particular, any practice that ‘materially distorts or is likely to materially distort the economic behaviour with regard to the product of the average consumer whom it reaches or to whom it is addressed’, provides that commercial practices which are in all circumstances considered to be unfair include ‘claiming that a trader (including his commercial practices) or a product has been approved, endorsed or authorised by a public or private body when he/it has not or making such a claim without complying with the terms of the approval, endorsement or authorisation’, and requires the ...[+++]Member States to adopt effective, proportionate and dissuasive penalties; whereas Directive 2005/29/EC states that ‘a commercial practice shall be regarded as misleading if it contains false information and is therefore untruthful or in any way, including overall presentation, deceives or is likely to deceive the average consumer, even if the information is factually correct’;

Mr. Mike Gifford, Director General, International Trade Policy Directorate, Market and Industry Services Branch, Agriculture and Agri-Food Canada: Mr. Chairman and honourable senators, I know that you would prefer to ask questions rather than to hear us go on at length, so I will quickly sketch out some of the major highlights we have experienced in our agricultural relationship with the United States, particularly since the conclusion of the Canada-U.S. Free Trade Agreement.

I know right now there's an agreement between the OECD, the United States, and Japan to try to come up with a set of very basic screens and assays just for a quick run-through of chemicals, so that we can run through the 87,000 in the United States, the 70,000 generally, and mainly the 15,000 chemicals that are being used in very high volume and widely dispersed into the environment and into our homes.